Richard N. Bergman , PhD

Research Interests

There are 3 independent laboratories in this Department doing research closely related to diabetes mellitus. The directors of these laboratories are J. Youn, C. Sung and R.N. Bergman. In sum, these investigators are studying different aspects of the causes of so-called non-insulin dependent diabetes mellitus (NIDDM), a disease which afflicts 14,000,000 Americans, and which is a primary cause of heart disease, blindness, and kidney disease. Thus, if we could cure or prevent NIDDM, we would do much to improve the overall health of the U.S. population. Because NIDDM is particularly prevalent in minority communities, i.e., the Hispanic and African-American populations, it is particularly important that we study its causes and cures.

Dr. Bergman and his colleagues include approximately 20 individuals, including 10 scientists at various levels of accomplishment (faculty level, postdoctoral level and graduate students), and 10 highly qualified technical and administrative personnel. These individuals are working on many different projects, ranging from cell biology to epidemiology and population genetics, but all related to diabetes research. Our work is supported primarily by the National Institutes of Health, but also by the American Diabetes Association. The primary projects are described as follows.

Causes of NIDDM: We have focused on several conditions which contribute to diabetes. In particular we have developed the "minimal model method" which is used to measure defects which, in time, cause diabetes. These defects are insulin resistance, insulin secretory deficiency, and reduced glucose effectiveness. We are investigating the importance of insulin transport across the endothelial barrier, from blood to tissue interstitial fluid as a contributor to insulin resistance. We have discovered that the transport is not due to a receptor-mediated process.

We are studying the influence of transendothelial transport in the signal transmission from the site of insulin release (b-cells of the pancreas) to the site of insulin action (the insulin sensitive cells -- primarily muscle). We are studying the relationship between insulin action to enhance glucose utilization in muscle, and the action of insulin to suppress the endogenous production of glucose by the liver. We have discovered that these two processes are coupled via the blood-borne compounds free fatty acids (FFA). The hypothesis is being tested that peripheral and hepatic insulin resistance are related and due to a single mechanism -- reduced insulin signaling in muscle and adipose tissue which results is less glucose uptake and less suppression of FFA and hence less reduction in glucose output.

The role of glucose effectiveness in carbohydrate metabolism was pioneered in this laboratory. This process is the effect of glucose itself to enhance its own uptake (and suppress its own endogenous production) independent of insulin. We have demonstrated that effectiveness is reduced in diabetes, and are now examining its mechanisms to determine why it is so suppressed. We have demonstrated that most of the carbohydrate utilization in the NIDDM state is due to glucose effectiveness, thus enhancing its potential importance as a mechanism leading to NIDDM.

Hypoglycemia, or low blood sugar is an important companion to the treatment of Type 1 diabetes (juvenile, or insulin-dependent diabetes) with insulin. Hypoglycemia results due to overtreatment with insulin in this type of diabetes. Investigators are interested in the mechanisms by which the body responds to hypoglycemia when it occurs. We have recently demonstrated that the liver possesses specific cells which can respond to hypoglycemia and signal the brain to mount a counter-regulatory response. This latter response includes, but is not limited to an increase in "adrenaline" (i.e., epinephrine) in the blood. We are studying the mechanisms by which the liver detects the hypoglycemic signal, and how this is altered in the experimental diabetic conditions. We hope to determine the cells of the liver which respond to low blood sugar, and determine how hypoglycemia is sensed and converted to a nervous signal to the brain.

Additional studies in this laboratory relate to the use of mathematical modeling to understand the integration of the transfer of carbon amongst the various metabolic reactions in the heart and the liver. We can represent complex metabolic interactions on the computer and from these deduce how metabolic fluxes change in different metabolic conditions.

For further information please click here.

Degrees

University of Pittsburgh, PHD, 1971